BOX 5-1Selected Existing Classifications of Biological Agents

Centers for Disease Control and Prevention (reproduced from <http://www.bt.cdc.gov/agent/agentlist-category.asp>)

Category A: High-priority agents include organisms that pose a threat to national security because they:

  • can be easily disseminated or transmitted from person to person;
  • result in high mortality rates and have the potential for major public health impact;
  • might cause public panic and social disruption; and
  • require special action for public health preparedness.

Category A agents/disease include anthrax (Bacillus anthracis), botulism (Clostridium botulinim toxin), plague (Yersinia pestis), smallpox (variola major), tularemia (Francisella tularensis), and viral hemorrhagic fevers (filoviruses [e.g., Ebola, Marburg] and arenaviruses [e.g., Lassa, Machupo]).

Category B: Second highest priority agents include those that:

  • are moderately easy to disseminate;
  • result in moderate morbidity rates and low mortality rates; and
  • require specific enhancements of CDC’s diagnostic capacity and enhanced disease surveillance.

Category B agents/diseases include brucellosis (Brucella species), epsilon toxin of Clostridium perfringens, food safety threats (e.g., Salmonella species, Escherichia coli O157:H7, Shigella), glanders (Burkholderia mallei), melioidosis (Burkholderia pseudomallei), Psittacosis (Chlamydia psittaci), Q fever (Coxiella burnetii), ricin toxin from Ricinus communis (castor beans), staphylococcal enterotoxin B, typhis fever (Rickettsia prowazekii), viral encephalitis (alphaviruses [e.g., Venezuelan equine encephalitis, eastern equine encephalitis, western equine encephalitis]), water safety threats (e.g., Vibrio cholerae, Cryptosporidium parvum).

Category C: Third highest priority agents include emerging pathogens that could be engineered for mass dissemination in the future because of:

  • availability;
  • ease of production and dissemination;
  • potential for high morbidity and mortality rates and major health impact.

Category C agents include emerging infectious diseases such as Nipah virus and hantavirus.

National Institutes of Health

NIH Guidelines (available at <http://oba.od.nih.gov/oba/rac/guidelines_02/APPENDIX_B.htm>)

  • Risk Group 1 (RG1): Agents that are not associated with disease in healthy adult humans.
  • RG2: Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available.
  • RG3: Agents that are associated with serious or lethal human disease for which preventive or therapeutic interventions may be available (high individual risk but low community risk).
  • RG4: Agents that are likely to cause serious or lethal human disease for which preventive or therapeutic interventions are not usually available (high individual risk and high community risk).

From: 5, Managing BSAT Research and the Select Agent Program

Cover of Responsible Research with Biological Select Agents and Toxins
Responsible Research with Biological Select Agents and Toxins.
National Research Council (US) Committee on Laboratory Security and Personnel Reliability Assurance Systems for Laboratories Conducting Research on Biological Select Agents and Toxins.
Washington (DC): National Academies Press (US); 2009.
Copyright © 2009, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.